Trial NCT00544778

View at ClinicalTrials.gov 
Org. Study IDs: 00050
Secondary IDs: CDR0000566381 CHNMC-00050 P30CA033572

Last trial update was posted on 2014-08-28

MeSH Interventions

Dexrazoxane Doxorubicin Ifosfamide Irinotecan Liposomal doxorubicin Razoxane

MeSH Conditions

Osteosarcoma Sarcoma

Other Conditions


Stopping Reasons

The study was terminated prematurely due to withdrawal of support by the sponsor.

Limitations And Caveats

The study was terminated…protocol objectives not met. It was closed prematurely due to withdrawal of support by the sponsor. Subjects have been followed, but there is not enough data generated to continue following the subjects."

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID